Farmeconomia-Health Economics and Therapeutic Pathways

Scope & Guideline

Unlocking the value of therapeutics through comprehensive evaluations.

Introduction

Explore the comprehensive scope of Farmeconomia-Health Economics and Therapeutic Pathways through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Farmeconomia-Health Economics and Therapeutic Pathways in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN1721-6915
PublisherSEED MEDICAL PUBLISHERS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationFARMECONOMIA / Farmeconomia
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA MAGENTA, 35, TORINO 10128, ITALY

Aims and Scopes

The journal 'Farmeconomia-Health Economics and Therapeutic Pathways' focuses on the intersection of health economics and therapeutic strategies. It aims to provide insights into the economic aspects of healthcare decisions, emphasizing cost-effectiveness, budget impact, and quality of life assessments in various therapeutic areas.
  1. Health Economics and Pharmacoeconomics:
    The journal emphasizes the economic evaluation of healthcare interventions, including cost-effectiveness analyses and pharmacoeconomic assessments to inform drug pricing and reimbursement decisions.
  2. Health Technology Assessment (HTA):
    It covers comprehensive evaluations of health technologies, assessing their clinical effectiveness, safety, and economic impact, which is essential for informed policy-making.
  3. Real-World Evidence (RWE):
    The journal highlights the importance of real-world evidence in understanding treatment effectiveness and patient outcomes outside controlled clinical trials.
  4. Patient-Centered Outcomes:
    Research often focuses on the impact of treatments on patient quality of life and healthcare resource utilization, ensuring that patient perspectives are central to economic evaluations.
  5. Cost Analysis in Specific Disease Areas:
    The scope includes detailed economic analyses for various diseases, such as diabetes, cancer, and mental health disorders, providing insights into the financial implications of different treatment strategies.
The journal is currently witnessing several emerging themes that reflect the evolving landscape of healthcare economics and therapeutic pathways. These trends highlight the increasing complexity of healthcare decisions and the importance of comprehensive evaluations.
  1. Long-Acting Injectable Therapies:
    There is a growing focus on the clinical and economic potential of long-acting injectable therapies, particularly in mental health and chronic conditions, reflecting a shift towards treatments that improve adherence and outcomes.
  2. Biosimilars and Their Economic Implications:
    Research on biosimilars, including their procurement and budget impact, is trending upward as healthcare systems look for cost-effective alternatives to expensive biologics.
  3. Budget Impact Analyses in Vaccination Programs:
    The importance of budget impact analyses in vaccination strategies, particularly for influenza and other vaccines, is gaining traction as public health priorities shift towards preventative healthcare.
  4. Integrated Care Models and Multi-Disease Approaches:
    Emerging studies are increasingly examining integrated care models that address multiple chronic conditions simultaneously, reflecting a holistic approach to patient management and economic evaluation.
  5. Use of Wearable Health Technologies:
    The assessment of wearable health technologies and their impact on patient management and health outcomes is becoming a prominent theme, driven by advancements in technology and patient engagement.

Declining or Waning

While the journal maintains a robust focus on health economics and therapeutic pathways, certain themes appear to be losing prominence in recent publications. This may reflect shifts in the healthcare landscape or emerging priorities in research.
  1. Traditional Cost-Benefit Analyses:
    There has been a noticeable decline in traditional cost-benefit analyses that do not incorporate broader patient-centered outcomes or real-world evidence, suggesting a shift towards more comprehensive evaluation frameworks.
  2. Generic Drug Assessments:
    Research specifically focused on the economic evaluation of generic drugs seems to be waning, potentially due to a saturation of studies in this area and a preference for innovative therapies.
  3. Single-Disease Focus Studies:
    There appears to be a reduction in studies concentrating solely on single-disease economic evaluations, with an increasing trend toward integrated care models that consider multiple conditions and their interactions.
  4. Basic Economic Modelling Techniques:
    The journal has seen fewer publications relying on basic economic modelling techniques, with a growing preference for sophisticated models that incorporate real-world complexities and uncertainties.

Similar Journals

Gesundheitsoekonomie und Qualitaetsmanagement

Navigating the Complexities of Healthcare Economics
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

Value in Health Regional Issues

Innovating Health Policy with Regional Perspectives.
Publisher: ELSEVIERISSN: 2212-1099Frequency: 3 issues/year

Value in Health Regional Issues, published by Elsevier, is an essential academic journal that addresses critical developments in the field of health economics, policy, and pharmaceuticals. With an impressive impact factor, this journal has established itself as a leading platform for disseminating innovative research, evidenced by its Q1 quartile ranking in Economics, Econometrics and Finance and Pharmacology, Toxicology and Pharmaceutics. Founded in 2012, the journal is dedicated to exploring value-based healthcare, focusing on regional perspectives that highlight economic implications and health outcomes. Covering a convergence of multidisciplinary themes, the journal fosters academic collaboration and provides researchers, professionals, and students with access to high-quality, peer-reviewed articles. As it continues to expand its scope through 2025, Value in Health Regional Issues remains a pivotal resource for those seeking to understand and influence health policy and economic frameworks on a regional, national, and global scale.

JAMA Internal Medicine

Shaping the Future of Patient Care with Cutting-Edge Insights
Publisher: AMER MEDICAL ASSOCISSN: 2168-6106Frequency: 12 issues/year

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

AMERICAN JOURNAL OF MANAGED CARE

Driving innovation in health policy and managed care.
Publisher: MANAGED CARE & HEALTHCARE COMMUNICATIONS LLCISSN: 1088-0224Frequency: 12 issues/year

AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.

Journal of Comparative Effectiveness Research

Transforming healthcare through evidence-based insights.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

VALUE IN HEALTH

Empowering Decision-Makers with Cutting-Edge Health Research
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

ClinicoEconomics and Outcomes Research

Pioneering Research for Economic Efficiency in Healthcare
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6981Frequency: 1 issue/year

ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Empowering research that shapes the future of health technology.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0266-4623Frequency: 1 issue/year

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE is a leading academic journal published by Cambridge University Press, specializing in the critical evaluation of healthcare technologies and their impact on health policy. Established in 1970, it has gained recognition within the field, currently holding a prestigious Q2 ranking in Health Policy, with a commendable position of #89 out of 310 in the Scopus rankings, placing it in the 71st percentile. The journal serves as an essential platform for researchers, professionals, and students interested in the intersection of technology and health care, facilitating the dissemination of innovative research findings and practical assessments that inform policy-making and improve health outcomes. With a focus on advancing knowledge from 1985 to 2024, the journal's content remains relevant and impactful. Though not open access, it offers subscription-based access to a wealth of articles that contribute to shaping the future of healthcare technology assessment.

Applied Health Economics and Health Policy

Shaping health policy with evidence-based economic insights.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

CURRENT MEDICAL RESEARCH AND OPINION

Transforming Opinions into Evidence-Based Practices.
Publisher: TAYLOR & FRANCIS LTDISSN: 0300-7995Frequency: 12 issues/year

CURRENT MEDICAL RESEARCH AND OPINION, published by Taylor & Francis Ltd, is a distinguished journal that has been at the forefront of medical research since its inception in 1972. With a vested interest in advancing healthcare knowledge, this journal encompasses a wide array of disciplines within the medical field, categorizing itself in Q2 of the Medicine (Miscellaneous) category according to the 2023 rankings. Notably, it holds a commendable rank of #119 out of 636 in the General Medicine category on Scopus, indicating its relevance and influence within the medical community, supported by an 81st percentile ranking. Although it does not present Open Access options, the comprehensive research articles, systematic reviews, and expert opinions it publishes are crucial for researchers, clinicians, and students who seek to deepen their understanding and drive innovations in medical practice. With its commitment to high-quality and impactful scientific communication, CURRENT MEDICAL RESEARCH AND OPINION remains an essential resource for those dedicated to advancing healthcare and improving patient outcomes.